Survival Comparable With Bevacizumab, Cetuximab in mCRC
August 26th 2014Frontline therapy with bevacizumab or cetuximab combined with either FOLFOX or FOLFIRI yielded a comparable survival benefit of approximately 29 months in patients with KRAS wild-type metastatic colorectal cancer (mCRC), according to results from the phase III CALGB/SWOG 80405 trial.
Most Patients Don't Opt for Breast Reconstruction and They Don't Regret It
August 20th 2014Even though universal coverage for postmastectomy breast reconstruction is mandated, a new study has found that the majority of women are deciding not to undergo breast reconstruction surgery following a mastectomy.
Can NSAIDs Help Prevent Recurrence in Overweight Breast Cancer Patients?
August 19th 2014Researchers at The University of Texas at Austin have found that postmenopausal overweight or obese breast cancer patients receiving hormone therapy as part of their treatment who use nonsteroidal anti-inflammatory drugs (NSAIDs) have significantly lower breast cancer recurrence rates and a sizable delay in time to cancer recurrence.
Providing Hope for Patients With Pancreatic Disease
August 14th 2014The National Pancreas Foundation (NPF) provides hope for those suffering from pancreatitis and pancreatic cancer through funding cutting-edge research, advocating for new and better therapies, and providing support and education for patients, caregivers, and healthcare professionals.
Study Supports Mammography in Women 75 Years and Older
August 14th 2014According to researchers at the University of Washington, the benefits of mammography extend to women older than 75 years, and the findings have the potential to change public health recommendations for breast cancer screening.
Study Finds Mouth Rinse Alleviates Oral Mucositis Symptoms in Head and Neck Cancers
August 13th 2014A growing understanding of the biological pathways at work in the development of oral mucositis in patients treated with cytotoxic cancer therapies has helped spur interest in steering symptom management away from "institutional folklore" rinses and anecdotal approaches toward evidence-based strategies
FDA Approves First DNA-Based CRC Screening Tool
August 12th 2014The FDA has approved Cologuard as the first noninvasive stool-based DNA test for the detection of colorectal cancer (CRC) in asymptomatic individuals at average risk, based on clinical trial results demonstrating superiority to the fecal immunochemical test (FIT).
Exercise Lowers Breast Cancer Risk, But Benefits Fade When Activity Stops
August 12th 2014A new study has found that postmenopausal women who undertook regular physical activity equivalent to at least 4 hours of walking per week in the last 4 years had a lower risk for invasive breast cancer compared with women who exercised less during those 4 years.
PALB2, BRCA2 Gene Mutations Confer Similar Breast Cancer Risk
August 8th 2014Women harboring a loss-of-function mutation in the PALB2 gene demonstrated an increased risk of developing breast cancer that was similar to the predisposition seen with mutations in the infamous BRCA gene, according to a study published in The New England Journal of Medicine (NEJM).
Many Benefits Seen With CT Lung Cancer Screening for Those at High Risk
August 7th 2014When the US Preventive Services Task Force (USPSTF) recommended last year that asymptomatic, high-risk individuals should receive annual screening for lung cancer with low-dose computed tomography (LDCT), it made a healthy decision for the American population.
Fewer Side Effects, Cost Savings, With Single-Fraction Radiotherapy for Bone Metastases
August 6th 2014A new study has found that standardizing prescribing practices for single-fraction radiation therapy (SFRT) for palliation of bone metastases may result in cost savings and an improvement in patients' quality of life.
Addario Lung Cancer Medical Institute Launches New Study, Featured on ABC News
August 5th 2014The Addario Lung Cancer Medical Institute (ALCMI) today launched a new study, the Genomics of Young Lung Cancer, to understand why lung cancer occurs in young adults, who quite often are athletic, never smokers and do not exhibit any of the known lung cancer genetic mutations.
Ambitious Lung-MAP Trial Launched With Five Novel Drugs
August 1st 2014Five novel agents for the treatment of patients with advanced squamous cell carcinoma of the lung will be evaluated in the recently launched Lung-MAP trial, an innovative biomarker-driven study that aims to improve the drug development process while exploring therapeutic options for this challenging malignancy.
Acupuncture Offers Quality-of-Life Benefits for Patients Taking AIs
July 30th 2014A new study led by researchers at the Perelman School of Medicine at the University of Pennsylvania has shown that electroacupuncture produces significant improvements in fatigue, anxiety, and depression in as little as 8 weeks for early-stage breast cancer patients experiencing joint pain related to the use of aromatase inhibitors (AIs).